Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients

Basit Öğe Kaydı
dc.authorwosidKaplan, Mustafa/D-4977-2014
dc.contributor.authorAtakan, Irfan H.
dc.contributor.authorKaplan, Mustafa
dc.contributor.authorSeren, Gulay
dc.contributor.authorAktoz, Tevfik
dc.contributor.authorGul, Hatice
dc.contributor.authorInci, Osman
dc.date.accessioned2024-06-12T11:16:59Z
dc.date.available2024-06-12T11:16:59Z
dc.date.issued2007
dc.departmentTrakya Üniversitesien_US
dc.description.abstractMany theories have been put forward to explain the mechanism of stone formation and growth. The aim of this study was to investigate the urinary, serum and stone levels of zinc, iron, magnesium, and copper in patients with calcium oxalate stones and to investigate urinary and serum element levels in healthy controls and to find a possible connection between the elements and calcium oxalate stone formation. A total of 104 patients with calcium oxalate stones ranging in age from 3 to 79 years (mean 44.0 +/- 18.1) and 77 healthy controls ranging in age from 18 to 77 (mean 44.2 +/- 17.9) were included in this study. The mean urinary iron and copper levels in stone patients were significantly higher than healthy controls (P = 0.000). The mean urinary zinc and magnesium levels in healthy controls were significantly higher than stone patients (P = 0.000). There was no significant difference in the serum levels of magnesium and copper in stone patients and healthy controls. Serum zinc and iron level were significantly high in healthy controls as compared to stone patients. Each stone had all 4 elements. Zn and Mg have inhibitory effect on calcium oxalate stone formation. Fe and Cu could be promotor of the calcium oxalate stone formation.en_US
dc.identifier.doi10.1007/s11255-006-9050-4
dc.identifier.endpage356en_US
dc.identifier.issn0301-1623
dc.identifier.issue2en_US
dc.identifier.pmid17203355en_US
dc.identifier.scopus2-s2.0-34447316113en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage351en_US
dc.identifier.urihttps://doi.org/10.1007/s11255-006-9050-4
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24526
dc.identifier.volume39en_US
dc.identifier.wosWOS:000247976000001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Urology And Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectUrolithiasisen_US
dc.subjectZincen_US
dc.subjectIronen_US
dc.subjectMagnesiumen_US
dc.subjectCopperen_US
dc.subjectCalcium Oxalateen_US
dc.subjectTrace-Metalsen_US
dc.subjectUrolithiasisen_US
dc.subjectDeficiencyen_US
dc.subjectInhibitorsen_US
dc.subjectFormersen_US
dc.titleSerum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu